Literature DB >> 7855901

The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs.

J L Wallace1, G Cirino.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7855901     DOI： 10.1016/0165-6147(94)90083-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  14 in total

1.  21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.

Authors:  M Paul-Clark; P Del Soldato; S Fiorucci; R J Flower; M Perretti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 3.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

4.  NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.

Authors:  C Cicala; A Ianaro; S Fiorucci; A Calignano; M Bucci; R Gerli; L Santucci; J L Wallace; G Cirino
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 5.  Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem.

Authors:  N M Davies; J L Wallace
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

6.  Pharmacology of nonsteroidal antiinflammatory drugs and opioids.

Authors:  Dick Slater; Sushama Kunnathil; Joseph McBride; Rajah Koppala
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

Review 7.  Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions.

Authors:  J A Balfour; A Fitton; L B Barradell
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 8.  Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.

Authors:  N M Davies; J L Wallace
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

9.  Induction of cytochrome P-450 BM-3 (CYP 102) by non-steroidal anti-inflammatory drugs in Bacillus megaterium.

Authors:  N English; V Hughes; C R Wolf
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

10.  Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety.

Authors:  A E Chávez-Piña; L Vong; W McKnight; M Dicay; R C O Zanardo; M I Ortiz; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.